Based on the previous evidence of association between MBL2 genetic polymorphisms and COVID-19 severity (31), we investigated a potential correlation between MBL deficiency, or low MBL levels, and the development of brain fog after COVID-19. The gene discussed is MBL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.